hepatoma

Showing 1 - 24 of 24

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Hepatocellular, Hepatoma Trial in Seongnam, Seoul (Regorafenib/Nivolumab)

Completed
  • Carcinoma, Hepatocellular
  • Hepatoma
  • Seongnam, Korea, Republic of
  • +2 more
Dec 4, 2022

Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Worldwide (Nivolumab, Relatlimab)

Recruiting
  • Hepatocellular Carcinoma
  • +4 more
  • Nivolumab
  • Relatlimab
  • Ciudad de Buenos Aires, Buenos Aires, Argentina
  • +74 more
Nov 11, 2022

Liver Cancer, Hepatoma Trial (Yttrium 90 (TheraSphere))

Completed
  • Liver Cancer
  • Hepatoma
  • Yttrium 90 (TheraSphere)
  • (no location specified)
Sep 28, 2022

Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Charlotte (Transarterial embolization, Microwave Ablation)

Terminated
  • Hepatocellular Carcinoma
  • +4 more
  • Transarterial embolization
  • Microwave Ablation
  • Charlotte, North Carolina
    Carolinas Medical Center
Apr 20, 2022

Hepatocellular Carcinoma, Hepatoma Trial in Baltimore (sorafenib, LC Bead-TACE)

Completed
  • Hepatocellular Carcinoma
  • Hepatoma
  • Baltimore, Maryland
    The Johns Hopkins Hospital
Oct 15, 2021

Hepatocellular Carcinoma, Liver Cancer, Hepatoma Trial in New York (Bead Block microspheres, Bead + Dox Arm)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Bead Block microspheres
  • Bead + Dox Arm
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 30, 2021

Hepatoma, Pancreas Cancer Trial in Bangkok Noi (Thoracic continuous epidural analgesia)

Recruiting
  • Hepatoma
  • Pancreas Cancer
  • Thoracic continuous epidural analgesia
  • Bangkok Noi, Bangkok, Thailand
    Faculty of Medicine Siriraj Hospital, Mahidol University
Jun 8, 2021

Unresectable Hepatocellular Carcinoma With TheraSphere®

Completed
  • Liver Tumors
  • +3 more
  • TheraSphere®
  • Orange, California
    The Center for Cancer Prevention & Treatment at St. Joseph Hospi
Apr 1, 2021

Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial in United States (DEB-TACE, Sorafenib)

Terminated
  • Hepatocellular Carcinoma
  • +2 more
  • Birmingham, Alabama
  • +5 more
Jan 25, 2021

Esophagus Cancer, Hepatoma, Glioma Trial in Zhengzhou (CAR-T/TCR-T cells immunotherapy)

Unknown status
  • Esophagus Cancer
  • +3 more
  • CAR-T/TCR-T cells immunotherapy
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Feb 3, 2021

Carcinoma, Hepatocellular, Hepatoma Trial in United States (SIR-Spheres microspheres)

Terminated
  • Carcinoma, Hepatocellular
  • Hepatoma
  • SIR-Spheres microspheres
  • Philadelphia, Pennsylvania
  • +3 more
Nov 16, 2020

Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial (Elbasvir / Grazoprevir Oral Tablet)

Withdrawn
  • Hepatocellular Carcinoma
  • +3 more
  • Elbasvir / Grazoprevir Oral Tablet
  • (no location specified)
Sep 6, 2020

Cancer of the Liver, Liver Cancer, Hepatoma Trial in Minneapolis (Salmonella typhimurium)

Completed
  • Cancer of the Liver
  • +4 more
  • Salmonella typhimurium
  • Minneapolis, Minnesota
    Edward W. Greeno, MD
Jul 6, 2020

B-cell Acute Lymphoblastic Leukemia, Lymphoma, Myeloid Leukemia Trial in Zhengzhou (CAR-T cell immunotherapy)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +15 more
  • CAR-T cell immunotherapy
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Dec 10, 2019

Hepatoma, Liver Tumors, Adenoma, Liver Cell Trial run by the NCI (TRC 105, Sorafenib)

Completed
  • Hepatoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 2, 2019

Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Worldwide (TKM-080301)

Completed
  • Hepatocellular Carcinoma
  • +3 more
  • Tucson, Arizona
  • +14 more
Jan 14, 2019

Hepatoma, Advanced Solid Tumor Trial in New York (irinotecan and ON 01910.Na, oxaliplatin and ON 01910.Na)

Completed
  • Hepatoma
  • Advanced Solid Tumor
  • irinotecan and ON 01910.Na
  • oxaliplatin and ON 01910.Na
  • New York, New York
    Mount Sinai Medical Center
Jun 22, 2017

Hepatocellular Carcinoma, Hepatoma, Cholangiocarcinoma Trial in Tokyo (Sevoflurane, Desflurane)

Unknown status
  • Hepatocellular Carcinoma
  • +3 more
  • Tokyo, Japan
    Tokyo Medical and Dental University
Apr 20, 2016

Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult Trial in Los Angeles, Pittsburgh (AFP + GM-CSF Plasmid Prime and AFP

Terminated
  • Hepatocellular Carcinoma
  • +13 more
  • AFP + GM-CSF Plasmid Prime and AFP Adenoviral Vector Boost
  • Los Angeles, California
  • +1 more
Dec 1, 2015

Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatoma Trial in Milwaukee (Sorafenib, Conventional fractionation (2 Gy per

Withdrawn
  • Hepatocellular Carcinoma
  • +3 more
  • Sorafenib
  • Conventional fractionation (2 Gy per day) external beam radiation therapy
  • Milwaukee, Wisconsin
    Froedtert Memorial Lutheran Hospital
Sep 4, 2013

Hepatoma, Cinobufacin Injection Trial in Shanghai (Cinobufacin injection)

Unknown status
  • Hepatoma
  • Cinobufacin Injection
  • Cinobufacin injection
  • Shanghai, Shanghai, China
    Department of TCM, Changhai Hospital of Shanghai
Jun 27, 2011

Liver Cirrhosis, Hepatoma Trial in Taipei city (propranolol)

Unknown status
  • Liver Cirrhosis
  • Hepatoma
  • Taipei city, Taiwan
    Veteran General Hospital-Taipei
Jun 14, 2011

Cancer, Liver Cancer, Primary Liver Cancer Trial in Worldwide (PI-88, )

Terminated
  • Cancer
  • +4 more
  • United States of America, New York
  • +9 more
Jun 13, 2011

Hepatocellular Carcinoma, Hepatoma, Cholangiocarcinoma Trial in Temple (Endoscopy ultrasound)

Unknown status
  • Hepatocellular Carcinoma
  • +3 more
  • Endoscopy ultrasound
  • Temple, Texas
    Central Texas Veterans health Care System
Jun 5, 2006